Fusen Pharmaceutical : PROPOSALS FOR GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES, RE-ELECTION OF DIRECTORS, RE-APPOINTMENT OF AUDITORS, DECLARATION OF FINAL DIVIDEND, AMENDMENTS TO THE MEMORANDUM AND THE ARTICLES, ADOPTION OF THE AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION AND NOTICE OF ANNUAL GENERAL MEETING
April 28, 2022 at 08:54 am EDT
Share
[title]
[date]
[link]
[market]
[doc type]
[stock code]
[stock name]
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
28/04/2022 20:34
Link
SEHK
htm
02196
FOSUN PHARMA
FORM OF PROXY FOR THE ANNUAL GENERAL MEETING (THE "AGM") TO BE HELD ON THURSDAY, 2 JUNE 2022 AT 3:00 P.M.
28/04/2022 20:34
Link
SEHK
pdf
01940
CGII HLDGS
NOTICE OF ANNUAL GENERAL MEETING
28/04/2022 20:34
Link
SEHK
pdf
01332
TOUYUN BIOTECH
REPLY SLIP FOR H SHAREHOLDERS' CLASS MEETING TO BE HELD ON FRIDAY, 20 MAY 2022
28/04/2022 20:34
Link
SEHK
pdf
01296
GUODIAN TECH
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
28/04/2022 20:33
Link
SEHK
htm
02196
FOSUN PHARMA
MAJOR TRANSACTION IN RELATION TO THE DISPOSAL OF THE ENTIRE EQUITY INTEREST IN THE DISPOSAL COMPANY
28/04/2022 20:33
Link
SEHK
pdf
01628
YUZHOU GROUP
NOTICE OF ANNUAL GENERAL MEETING
28/04/2022 20:32
Link
SEHK
pdf
01940
CGII HLDGS
PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION
28/04/2022 20:32
Link
SEHK
pdf
01725
HK AERO TECH
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
28/04/2022 20:32
Link
SEHK
htm
02196
FOSUN PHARMA
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
28/04/2022 20:31
Link
SEHK
htm
02196
FOSUN PHARMA
FORM OF PROXY FOR THE H SHAREHOLDERS' CLASS MEETING TO BE HELD ON FRIDAY, 20 MAY 2022
28/04/2022 20:30
Link
SEHK
pdf
01296
GUODIAN TECH
PROPOSED RE-ELECTION OF DIRECTORS AND PROPOSED GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE SHARES AND NOTICE OF ANNUAL GENERAL MEETING
28/04/2022 20:30
Link
SEHK
pdf
01940
CGII HLDGS
Notification Letter and Request Form to Non-Registered Holders
28/04/2022 20:30
Link
SEHK
pdf
01332
TOUYUN BIOTECH
REVISION OF ANNUAL CAPS FOR CONTINUING CONNECTED TRANSACTIONS
28/04/2022 20:30
Link
SEHK
pdf
02880
LIAONING PORT
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
28/04/2022 20:29
Link
SEHK
htm
02196
FOSUN PHARMA
Annual Report 2021
28/04/2022 20:28
Link
SEHK
pdf
01940
CGII HLDGS
List of Directors and their Role and Function
28/04/2022 20:28
Link
SEHK
pdf
00517
COSCO SHIP INTL
Annual Report 2021
28/04/2022 20:27
Link
SEHK
pdf
01198
ROYALE HOME
ANNUAL REPORT 2021
28/04/2022 20:27
Link
SEHK
pdf
01652
FUSEN PHARM
NOTICE OF H SHAREHOLDERS' CLASS MEETING
28/04/2022 20:27
Link
SEHK
pdf
01296
GUODIAN TECH
Attachments
Original Link
Original Document
Permalink
Disclaimer
Fusen Pharmaceutical Company Ltd. published this content on 28 April 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 28 April 2022 12:52:05 UTC.
Fusen Pharmaceutical Co Ltd is a China-based company principally engaged in the provision of Shuanghuanglian series cold medicines. The Company is mainly engaged in research, development, production and sales of Chinese patent drugs and western medicine products for the treatment of cold and fever, cardiovascular diseases and anemia. The Company's main products include small volume injections, oral liquids, tablets, capsules and granules. The Company distributes its products mainly in domestic market.
Fusen Pharmaceutical : PROPOSALS FOR GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES, RE-ELECTION OF DIRECTORS, RE-APPOINTMENT OF AUDITORS, DECLARATION OF FINAL DIVIDEND, AMENDMENTS TO THE MEMORANDUM AND THE ARTICLES, ADOPTION OF THE AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION AND NOTICE OF ANNUAL GENERAL MEETING